In the present study, the function of BAP31 was investigated in HCC using in vitro and in vivo experiments; the data demonstrated that targeting BAP31 may be an effective strategy for treatment of advanced HCC. This evidence concerns the gene BCAP31 and hepatocellular carcinoma.